Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GELATIN for Hepatocellular carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where GELATIN was used for Hepatocellular carcinoma.

Most Reported Side Effects for GELATIN

Side Effect Reports % Deaths Hosp.
Off label use 35 28.9% 4 2
Device use issue 22 18.2% 4 0
Post embolisation syndrome 21 17.4% 4 0
Product use issue 18 14.9% 0 0
Hepatic artery stenosis 15 12.4% 0 0
Cholecystitis acute 12 9.9% 0 0
Aspartate aminotransferase increased 10 8.3% 0 0
Anaphylactic reaction 9 7.4% 0 3
Drug hypersensitivity 9 7.4% 0 2
Skin injury 9 7.4% 0 0
Cough 7 5.8% 0 2
Hypotension 6 5.0% 1 5
Product use in unapproved indication 6 5.0% 1 3
Abdominal injury 5 4.1% 0 0
Alanine aminotransferase increased 5 4.1% 0 0

Other Indications for GELATIN

Transcatheter arterial chemoembolisation (36) Therapeutic embolisation (23) Product used for unknown indication (18) Embolism (15)

Other Drugs Used for Hepatocellular carcinoma

ATEZOLIZUMAB (8,443) BEVACIZUMAB (7,773) LENVATINIB (5,384) SORAFENIB (4,986) CABOZANTINIB S-MALATE (2,670) DURVALUMAB (1,255) NIVOLUMAB (1,142) REGORAFENIB (1,050) TREMELIMUMAB\TREMELIMUMAB-ACTL (589) PEMBROLIZUMAB (518)

Related Pages

GELATIN Full Profile All Hepatocellular carcinoma Drugs GELATIN Demographics GELATIN Timeline